Quantcast

Md. firm gets $25M contract for nerve agent countermeasure

The U.S. State Department gave a one-year contract worth up to $25 million to Emergent BioSolutions Inc. of Gaithersburg to supply a drug and auto-injector that can be used to counter nerve agent or organophosphate. The drug, Trobigard, is designed to be administered into muscles prior to going to a hospital. The contract also has a six-month option. Emergent will ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*